Directorate Changes

RNS Number : 1614N

Venture Life Group PLC

30 May 2022

 

30^th May 2022

VENTURE LIFE GROUP PLC

("Venture Life" "VLG" or the "Group")

Directorate Changes

Venture Life (AIM: VLG), a leader in developing, manufacturing and commercialising products for the self-care market, announces that Mr Peter Bream, non-executive Director and Chair of the Audit Committee, after serving on the Board for seven years, has given the Company notice of his resignation in order to facilitate Director rotation in line with good corporate governance.

The Company also announces that Mr Carl Dempsey, non-executive Director and Chair of the Remuneration Committee will also be stepping down. Mr Dempsey has served on the Board of the Company for three years, but has decided that, due to the workload required from his other business interests, and accelerating new ventures, he is unable to continue to dedicate the required time to his position on the Board of Venture Life.

A search process has begun to replace both Mr Bream and Mr Dempsey, and they will both continue to serve on the Board of the Company until their replacements are appointed.

Jerry Randall, CEO of Venture Life commented: " I would like to extend my thanks to both Peter and Carl on behalf of myself and the whole team of Venture Life for all of their advice, support and input to the business over the time they have been with us. The business has grown significantly over their time with us, and in the last few years managed its way through significant challenges that the global markets have experienced. I wish both Peter and Carl the very best for their future endeavours."

Paul McGreevy, non-executive Chair of Venture Life commented: " It's clearly evident that both Peter and Carl's contribution to the business has been significant in our governance, compliance and growth, and have helped build a sustainable platform from which we can accelerate our ambitions. I'd like to thank them both for their professionalism and support given to Venture Life."

For further information, please contact:

Venture Life Group PLC		[phone]
Jerry Randall, Chief Executive Officer Daniel Wells, Chief Financial Officer
Cenkos Securities plc (Nomad and Joint Broker)		[phone]
Michael Johnson/Russell Kerr (Sales) Stephen Keys/Camilla Hume (Corporate Finance)
Singer Capital markets (Joint Broker)		[phone]
Jonathan Dighe (Sales) Shaun Dobson/Alaina Wong (Corporate Finance)

About Venture Life ( www.venture-life.com )

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the global self-care market. With operations in the UK, Italy, The Netherlands and Sweden, the Group's product portfolio includes some key products such as the UltraDEX and Dentyl oral care product ranges, the Balance Active range in the area of women's intimate healthcare, the Lift and Glucogel product ranges for hypoglycaemia, products for fungal infections and proctology, and dermo-cosmetics for addressing the signs of ageing. Its products are sold in over 90 countries worldwide.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies and grocery multiples. In the UK and The Netherlands these are supplied direct by the company to retailers, elsewhere they are supplied by the Group's international distribution partners. 

Through its two Development & Manufacturing operations in Italy and Sweden, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.

 

END

 

 

BOAFZGZKRLRGZZM